Article Details

Interim Data Targeting CD117 Show Promising MRD Results and Safety in MDS/AML

Retrieved on: 2022-04-27 18:43:07

Tags for this article:

Click the tags to see associated articles and topics

Interim Data Targeting CD117 Show Promising MRD Results and Safety in MDS/AML. View article details on hiswai:

Excerpt

JSP191 is a humanized monoclonal antibody meant to block stem cell factor ... showed synergy between anti-CD117 monoclonal antibodies and low-dose ...

Article found on: www.targetedonc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up